Actively Recruiting
Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)
Led by AbbVie · Updated on 2026-05-13
125
Participants Needed
17
Research Sites
121 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study will assess how effective foscarbidopa/ foslevodopa is in treating German adult participants at initial stages of advanced Parkinson's disease under routine clinical practice. Foslevodopa/Foscarbidopa is an approved drug for the treatment of Parkinson's Disease. Approximately 125 adult participants who are prescribed Foslevodopa/Foscarbidopa by their doctors will be enrolled across approximately 20 sites in Germany. Participants will receive Foslevodopa/Foscarbidopa subcutaneous infusion as prescribed by their physician. Participants will be followed for up to 12 months. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
CONDITIONS
Official Title
Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of levodopa-responsive idiopathic Parkinson's disease
- Eligible for foscarbidopa/foslevodopa therapy according to local approved label
- Adult male or female between 18 and 64 years old
- Motor fluctuations started 3 years ago or less
- Hoehn and Yahr stage less than 3 while on medication
- Decision to treat with foscarbidopa/foslevodopa made by clinician before approaching participant
You will not qualify if you...
- Previous use of any device-aided therapy
- Any condition listed as a contraindication in the local foscarbidopa/foslevodopa label
- Mini mental state examination (MMSE) score less than 24
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Universitaetsklinikum Heidelberg /ID# 274164
Heidelberg, Baden-Wurttemberg, Germany, 69120
Actively Recruiting
2
Universitaetsklinikum Tuebingen /ID# 275828
Tübingen, Baden-Wurttemberg, Germany, 72076
Actively Recruiting
3
Praxis Prof. Kassubek/Prof. Riecker /ID# 274165
Ulm, Baden-Wurttemberg, Germany, 89073
Actively Recruiting
4
Parkinson-Klinik Ortenau GmbH&Co KG /ID# 274161
Wolfach, Baden-Wurttemberg, Germany, 77709
Actively Recruiting
5
Universitaetsklinikum Erlangen /ID# 280831
Erlangen, Bavaria, Germany, 91054
Actively Recruiting
6
Klinikum Ingolstadt /ID# 280573
Ingolstadt, Bavaria, Germany, 85049
Actively Recruiting
7
Klinikum der Universitaet Muenchen Grosshadern /ID# 274168
Munich, Bavaria, Germany, 81337
Actively Recruiting
8
Klinikum Ernst von Bergmann /ID# 274176
Potsdam, Brandenburg, Germany, 14467
Actively Recruiting
9
Universitaetskliniken Giessen und Marburg /ID# 274224
Marburg, Hesse, Germany, 35043
Actively Recruiting
10
Knappschaftskrankenhaus Bottrop /ID# 274284
Bottrop, North Rhine-Westphalia, Germany, 46242
Actively Recruiting
11
Cellitinnen-NTC Neurologisches Therapiecentrum /ID# 277865
Cologne, North Rhine-Westphalia, Germany, 50668
Actively Recruiting
12
Klinikum Lippe Detmold /ID# 279451
Detmold, North Rhine-Westphalia, Germany, 32756
Actively Recruiting
13
Klinikum Dortmund Klinikzentrum Mitte /ID# 280222
Dortmund, North Rhine-Westphalia, Germany, 44137
Actively Recruiting
14
Universitaetsklinikum Carl Gustav Carus Dresden /ID# 274167
Dresden, Saxony, Germany, 01307
Actively Recruiting
15
Krankenhaus Martha-Maria Halle-Dölau /ID# 274174
Halle, Saxony-Anhalt, Germany, 06120
Actively Recruiting
16
Praxis MD Oehlwein /ID# 274222
Gera, Thuringia, Germany, 07551
Actively Recruiting
17
Asklepios Fachklinikum Stadtroda /ID# 274162
Stadtroda, Thuringia, Germany, 07646
Actively Recruiting
Research Team
M
Medical Information Germany
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here